Corrigendum to “Therapeutic potential of the sphingosine kinase 2 inhibitor opaganib” [Pharmaceut. Sci. Adv. 4, (2026), 100125]
Pharmaceutical Science Advances · 2026-12 · 4 · 100154
DOI: 10.1016/j.pscia.2026.100154 ↗Kurz gefasst
Korrektur in der Zeitschrift Pharmaceutical Science Advances, 2026-12. Verfasst von Fuxun Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, Sh…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- School of Pharmaceutical Sciences & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, Shandong, 250117, PR China.
- Department of Medicinal Chemistry, Key Laboratory of Chemical Biology, Ministry of Education, School of Pharmaceutical Sciences, Shandong University, Ji'nan, Shandong Province, 250012, PR China.
Zitieren
APA
Huang, F., Zhan, P., Shi, X., Sun, Y., Song, X., Sun, P., & Liu, B. (2026). Corrigendum to “Therapeutic potential of the sphingosine kinase 2 inhibitor opaganib” [Pharmaceut. Sci. Adv. 4, (2026), 100125]. Pharmaceutical Science Advances, 4, 100154. https://doi.org/10.1016/j.pscia.2026.100154
Vancouver
Huang F, Zhan P, Shi X, Sun Y, Song X, Sun P, et al. Corrigendum to “Therapeutic potential of the sphingosine kinase 2 inhibitor opaganib” [Pharmaceut. Sci. Adv. 4, (2026), 100125]. Pharmaceutical Science Advances. 2026;4:100154. doi:10.1016/j.pscia.2026.100154
BibTeX
@article{Huang2026,
author = {Huang, Fuxun and Zhan, Peng and Shi, Xiujuan and Sun, Yueyang and Song, Xingbo and Sun, Peilu and Liu, Bo},
title = {Corrigendum to “Therapeutic potential of the sphingosine kinase 2 inhibitor opaganib” [Pharmaceut. Sci. Adv. 4, (2026), 100125]},
journal = {Pharmaceutical Science Advances},
year = {2026},
volume = {4},
pages = {100154},
doi = {10.1016/j.pscia.2026.100154}
}
EUVIMED